Stocks and Investing Stocks and Investing
Tue, April 28, 2020
Mon, April 27, 2020

Matthew Mishan Maintained (AVNS) at Buy with Decreased Target to $45 on, Apr 27th, 2020


Published on 2024-10-27 04:15:53 - WOPRAI, Matthew Mishan
  Print publication without navigation


Matthew Mishan of Keybanc, Maintained "Avanos Medical, Inc." (AVNS) at Buy with Decreased Target from $48 to $45 on, Apr 27th, 2020.

Matthew has made no other calls on AVNS in the last 4 months.



There are 4 other peers that have a rating on AVNS. Out of the 4 peers that are also analyzing AVNS, 2 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Kristen Stewart of "Barclays" Upgraded from Sell to Hold on, Monday, April 13th, 2020
  • Rick Wise of "Stifel" Maintained at Hold with Decreased Target to $32 on, Wednesday, April 1st, 2020


These are the ratings of the 2 analyists that currently disagree with Matthew


  • David Lewis of "Morgan Stanley" Maintained at Sell with Decreased Target to $29 on, Friday, March 27th, 2020
  • Chris Cooley of "Stephens & Co." Maintained at Buy with Decreased Target to $30 on, Monday, March 23rd, 2020
Contributing Sources